John L. Knopf
Nessuna posizione attualmente
Profilo
John L.
Knopf is the founder of Acceleron Pharma, Inc. which was founded in 2003.
He held the titles of President, Chief Executive Officer & Director from 2013 to 2016.
Dr. Knopf's former jobs include being a Scientist at Genetics Institute LLC from 1982 to 1998 and Vice President-Metabolic & Respiratory Disease at Wyeth Research.
Dr. Knopf's education history includes an undergraduate degree from Stony Brook University and a doctorate from State University of New York at Buffalo.
Precedenti posizioni note di John L. Knopf
| Società | Posizione | Fine |
|---|---|---|
| ACCELERON PHARMA INC. | Founder | 01/12/2016 |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Corporate Officer/Principal | - |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Formazione di John L. Knopf
| Stony Brook University | Undergraduate Degree |
| State University of New York at Buffalo | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- John L. Knopf
